A 2026 study by Subhadip Choudhuri compares low-dose bicistronic immunotherapy (BCV/BCVR) with benznidazole (BZN) treatment in adult C57BL/6 mice infected with Trypanosoma cruzi. The dataset likely contains measurements of parasite burden, biomarkers of inflammation and fibrosis, and left ventricular function outcomes. Results indicate BCV/BCVR immunothepies outperformed BZN in controlling parasite persistence and ameliorating cardiac pathology.
Use Cases
- Compare treatment efficacy based on parasite burden measurements mentioned in the description
- Analyze biomarker correlations with cardiac pathology based on inflammation and fibrosis markers
- Evaluate left ventricular function outcomes based on systolic and diastolic performance data
Strengths
- 26.1 MB dataset available under CC-BY-4.0 license
- Comparative analysis of three distinct treatments (BCV, BCVR, BZN)
Limitations
- Column-level documentation is absent; field semantics must be inferred after download
- Row count is unknown, which may limit suitability assessment
Provenance
- Source
- figshare
- Collection Method
- Experimental study on adult C57BL/6 mice infected with Trypanosoma cruzi.
- Freshness
- Last updated 2026-05-25 12:06:43